Lantu Gou Selected Research

Lantu Gou Research Topics

Disease

25	Neoplasms (Cancer) 01/2024 - 04/2008
4	Carcinoma (Carcinomatosis) 01/2020 - 09/2009
3	Multiple Myeloma 12/2022 - 11/2012
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2009
3	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2011
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 01/2018
3	Ovarian Neoplasms (Ovarian Cancer) 12/2020 - 09/2014
3	Body Weight (Weight, Body) 12/2018 - 05/2016
2	Lewis Lung Carcinoma 05/2016 - 09/2009
2	Hepatocellular Carcinoma (Hepatoma) 08/2011 - 08/2011
2	Atherosclerosis 09/2007 - 09/2006
1	Breast Neoplasms (Breast Cancer) 08/2020
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Fatigue 05/2016
1	Alzheimer Disease (Alzheimer's Disease) 05/2016
1	Cachexia 05/2016
1	Necrosis 05/2016
1	Inflammation (Inflammations) 02/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2016
1	Peritoneal Neoplasms 03/2013
1	Hematologic Neoplasms (Hematological Malignancy) 11/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2008
1	Liver Neoplasms (Liver Cancer) 04/2008
1	Hypercholesterolemia 09/2007
1	Hyperlipidemias (Hyperlipidemia) 09/2007
1	Hypertriglyceridemia 11/2005

Drug/Important Bio-Agent (IBA)

7	Immunoconjugates (Immunoconjugate)IBA 08/2020 - 12/2015
4	Monoclonal AntibodiesIBA 12/2022 - 12/2015
4	Trastuzumab (Herceptin)FDA Link 08/2020 - 09/2014
3	Proteins (Proteins, Gene)FDA Link 07/2013 - 04/2008
2	Glycoproteins (Glycoprotein)IBA 12/2020 - 01/2018
2	CytokinesIBA 12/2020 - 02/2016
2	AntibodiesIBA 01/2017 - 12/2015
2	human ERBB2 proteinIBA 01/2017 - 09/2014
2	Interleukin-6 (Interleukin 6)IBA 02/2016 - 11/2012
2	isoliquiritigenin (GU 17)IBA 02/2016 - 11/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2015 - 12/2015
2	Biomarkers (Surrogate Marker)IBA 08/2011 - 09/2008
2	HDL LipoproteinsIBA 09/2007 - 11/2005
2	LipidsIBA 09/2007 - 09/2006
2	Lipoproteins (Lipoprotein)IBA 09/2007 - 09/2006
1	isatuximabIBA 12/2022
1	daratumumabIBA 12/2022
1	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 01/2022
1	GSK 1363089IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2020
1	Interleukin-2 (IL2)IBA 12/2020
1	Chimeric Antigen ReceptorsIBA 12/2020
1	AntigensIBA 12/2020
1	ProdrugsIBA 08/2020
1	cryptophycin 55IBA 08/2020
1	Therapeutic UsesIBA 08/2020
1	serum P-component (CIt)IBA 08/2020
1	Hydroxyl RadicalIBA 08/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	N-(2-hydroxypropyl)methacrylamide copolymer-paclitaxel conjugateIBA 01/2020
1	Saline SolutionIBA 01/2020
1	nilotinib FDA Link 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Tubulin ModulatorsIBA 08/2018
1	duocarmycin AIBA 01/2018
1	PlatinumIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	rhodiolosideIBA 05/2016
1	Cisplatin (Platino)FDA LinkGeneric 05/2016
1	GlycosidesIBA 05/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2016
1	Interleukin-8 (Interleukin 8)IBA 02/2016
1	Imiquimod (Aldara)FDA LinkGeneric 02/2016
1	Keratin-14 (Keratin 14)IBA 02/2016
1	CarbonatesIBA 12/2015
1	Ado-Trastuzumab EmtansineIBA 09/2014
1	Peptide Hydrolases (Proteases)FDA Link 07/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2012
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 08/2011
1	Interleukin-4 (Interleukin 4)IBA 08/2011
1	Hepatitis B e AntigensIBA 08/2011
1	honokiolIBA 09/2009
1	Messenger RNA (mRNA)IBA 09/2008
1	Hydroxamic Acids (Hydroxamic Acid)IBA 04/2008
1	Histone Deacetylase InhibitorsIBA 04/2008

Therapy/Procedure

11	Therapeutics 01/2024 - 09/2008
5	Immunotherapy 01/2024 - 01/2018
5	Drug Therapy (Chemotherapy) 01/2021 - 03/2013
4	Aftercare (After-Treatment) 12/2018 - 04/2008
1	Intraperitoneal Injections 09/2014
1	Biological Therapy 04/2009